Business Context and Reporting Period
This Form 8-K reports on the 2010 Annual Meeting of Stockholders for Harvard Bioscience, Inc., held on May 27, 2010. The filing details the outcomes of shareholder votes regarding director elections and the ratification of the independent auditor.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes
No material financial changes are reported in this document. The primary events are the successful election of two Class I Directors and the ratification of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2010.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It is a procedural report of voting results.
Important Facts for Investors
- Director Elections: Robert Dishman and Neal J. Harte were elected as Class I Directors for three-year terms.
- Voting Results - Directors: Robert Dishman received 19,324,096 votes for (4,486,340 withheld); Neal J. Harte received 22,011,732 votes for (1,798,704 withheld).
- Auditor Ratification: KPMG LLP was ratified as the independent auditor with 26,210,234 votes for, 185,430 against, and 6,969 abstained.
- Broker Non-Votes: There were 2,592,197 broker non-votes recorded for the director election proposals.